Major release: The impact of gout on Māori

on 9 December

Tēnā koutou, 

Pharmac has released the first in a series of research insights investigating inequities in medicine access. The report looks specifically at the prescribing and dispensing of medicines for gout, finding an estimated 10,400 more Māori need preventive treatment each year to achieve equity in access to medicines. 

You can find the full report, the methodology document, and the press release on the Pharmac website. 

Sharing these insights supports Te Rautaki o Te Whaioranga, Pharmac’s Māori Responsiveness Strategy, and our commitment to Te Tiriti o Waitangi. Our goal is to advance Māori health and aspirations – to achieve pae ora for Māori – through tino rangatiratanga, partnership, active protection, options, and equity. 

We are using the data and insights and working with our partners across the health and disability sector to see real changes from policy to primary healthcare. We’re also examining our own processes for improving access to funded medicines. 

Gout insights for Pacific peoples will be released shortly, and measures for cardiovascular disease, diabetes, asthma, and chronic obstructive pulmonary disease are being developed. 

You can get in touch with us at if you have any questions. 

Ngā mihi 


Alex Maplesden (he/his) | Senior Communications Advisor - Strategic
PHARMAC | Te Pātaka Whaioranga | PO Box 10-254 | Level 9, 40 Mercer Street, Wellington

Pharmac Te Pataka Whaioranga

Back to blog entries

Areas of Interest